SearchDictionaryMobileLogin

Eculizumab (Soliris) for paroxysmal nocturnal hemoglobinuria.

Authors
JournalThe Medical letter on drugs and therapeutics (Med Lett Drugs Ther) Vol. 49 Issue 1270 Pg. 79-80 (Sep 24 2007) ISSN: 1523-2859 United States
PMID17878890 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Hematologic Agents
  • eculizumab
Topics
  • Antibodies, Monoclonal (administration & dosage, adverse effects, economics, therapeutic use)
  • Drug Administration Schedule
  • Drug Costs
  • Hematologic Agents (administration & dosage, adverse effects, economics, therapeutic use)
  • Hemoglobinuria, Paroxysmal (drug therapy)
  • Humans
  • Infusions, Intravenous
  • Treatment Outcome